DocuSign Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
DocuSign wird ein jährliches Gewinn- und Umsatzwachstum von 27.3% bzw. 5.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 27.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 38% betragen.
Wichtige Informationen
27.2%
Wachstumsrate der Gewinne
27.1%
EPS-Wachstumsrate
| Software Gewinnwachstum | 15.6% |
| Wachstumsrate der Einnahmen | 5.8% |
| Zukünftige Eigenkapitalrendite | 38.0% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 26 Jul 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
DocuSign: The Profitability Narrative Deserves More Credit Than Slowing Growth
Jul 19An Intrinsic Calculation For DocuSign, Inc. (NASDAQ:DOCU) Suggests It's 35% Undervalued
Jul 01
DocuSign: AI Monetization And New Growth Opportunities Are Here, Reiterate Buy
Jun 29DocuSign: 33% FCF Margins, But Slowing Growth Is A Risk
Jun 18Shareholders Can Be Confident That DocuSign's (NASDAQ:DOCU) Earnings Are High Quality
Jun 16DocuSign: Why I See No Reason To Be Bullish Now
Jun 10DocuSign: Limited Downside Risk While Waiting On AI
Jun 02DocuSign (NASDAQ:DOCU) Is Looking To Continue Growing Its Returns On Capital
May 24Risks To Shareholder Returns Are Elevated At These Prices For DocuSign, Inc. (NASDAQ:DOCU)
May 09DocuSign: Debt-Free Status, With Increasing Profits
Apr 09Results: DocuSign, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Mar 24DocuSign, Inc. (NASDAQ:DOCU) Shares Could Be 36% Below Their Intrinsic Value Estimate
Mar 15DocuSign: Expand Into Contract Lifecycle; Normalized Billing Growth; Initiate With 'Buy'
Mar 09These 4 Measures Indicate That DocuSign (NASDAQ:DOCU) Is Using Debt Safely
Feb 29DocuSign: Why I Will Not Invest At Current Moment
Feb 27DocuSign: Wait For Growth Inflection Point As Buy-Out Fantasies Fade
Feb 14Buyout Or Not, DocuSign Can Shine
Feb 05DocuSign, Inc.'s (NASDAQ:DOCU) Shares May Have Run Too Fast Too Soon
Jan 25Is There Now An Opportunity In DocuSign, Inc. (NASDAQ:DOCU)?
Jan 12Solid Earnings Reflect DocuSign's (NASDAQ:DOCU) Strength As A Business
Dec 15Is DocuSign (NASDAQ:DOCU) A Risky Investment?
Nov 24The Return Trends At DocuSign (NASDAQ:DOCU) Look Promising
Oct 19Is DocuSign (NASDAQ:DOCU) Weighed On By Its Debt Load?
Jul 08There's Reason For Concern Over DocuSign, Inc.'s (NASDAQ:DOCU) Price
May 18Is DocuSign, Inc. (NASDAQ:DOCU) Trading At A 48% Discount?
May 03Is DocuSign (NASDAQ:DOCU) Using Debt Sensibly?
Mar 28Should You Think About Buying DocuSign, Inc. (NASDAQ:DOCU) Now?
Jan 24DocuSign, Inc. (NASDAQ:DOCU) Shares Could Be 24% Below Their Intrinsic Value Estimate
Dec 25Health Check: How Prudently Does DocuSign (NASDAQ:DOCU) Use Debt?
Nov 22Rowan Street Capital - DocuSign: No Owners, Just Newly Hired 'Agent-Operators'
Oct 17DocuSign: The Case For Upside Revaluation
Sep 28Where Will DocuSign Stock Be In 5 Years?
Sep 22DocuSign: Back In The Range
Sep 13DocuSign's Growth Trajectory Is Massively Uncertain
Sep 06DocuSign: Still On The Sidelines For Now
Aug 18Health Check: How Prudently Does DocuSign (NASDAQ:DOCU) Use Debt?
Aug 07DocuSign shares fall 5% as investors' uncertainty grows
Jul 26DocuSign: Downright Steal
Jul 17DocuSign Is Ripe To Be Acquired
Jun 23Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 1/31/2027 | 3,346 | 322 | 938 | 1,096 | 10 |
| 1/31/2026 | 3,110 | 228 | 897 | 1,001 | 21 |
| 1/31/2025 | 2,928 | 152 | 815 | 900 | 21 |
| 4/30/2024 | 2,810 | 107 | 905 | 1,001 | N/A |
| 1/31/2024 | 2,762 | 74 | 887 | 980 | N/A |
| 10/31/2023 | 2,709 | 52 | 752 | 846 | N/A |
| 7/31/2023 | 2,654 | -17 | 547 | 634 | N/A |
| 4/30/2023 | 2,589 | -70 | 469 | 544 | N/A |
| 1/31/2023 | 2,516 | -97 | 429 | 507 | N/A |
| 10/31/2022 | 2,437 | -133 | 386 | 457 | N/A |
| 7/31/2022 | 2,337 | -109 | 440 | 510 | N/A |
| 4/30/2022 | 2,227 | -89 | 497 | 567 | N/A |
| 1/31/2022 | 2,107 | -70 | 445 | 506 | N/A |
| 10/31/2021 | 1,957 | -112 | 419 | 481 | N/A |
| 7/31/2021 | 1,795 | -165 | 367 | 433 | N/A |
| 4/30/2021 | 1,625 | -204 | 305 | 373 | N/A |
| 1/31/2021 | 1,453 | -243 | 215 | 297 | N/A |
| 10/31/2020 | 1,297 | -218 | 186 | 280 | N/A |
| 7/31/2020 | 1,164 | -206 | 134 | 221 | N/A |
| 4/30/2020 | 1,057 | -210 | 46 | 129 | N/A |
| 1/31/2020 | 974 | -208 | 44 | 116 | N/A |
| 10/31/2019 | 899 | -227 | 51 | 104 | N/A |
| 7/31/2019 | 828 | -233 | 61 | 110 | N/A |
| 4/30/2019 | 759 | -201 | 67 | 107 | N/A |
| 1/31/2019 | 701 | -427 | 46 | 76 | N/A |
| 10/31/2018 | 650 | -367 | 52 | 74 | N/A |
| 7/31/2018 | 602 | -329 | 63 | 81 | N/A |
| 4/30/2018 | 561 | -305 | 52 | 71 | N/A |
| 1/31/2018 | 519 | -54 | N/A | 55 | N/A |
| 1/31/2017 | 381 | -117 | N/A | -5 | N/A |
| 1/31/2016 | 250 | -124 | N/A | -68 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: DOCUDas prognostizierte Gewinnwachstum (27.3% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: DOCUDie Erträge des Unternehmens (27.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (14.8% pro Jahr).
Hohe Wachstumserträge: DOCUEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: DOCUDie Einnahmen des Unternehmens (5.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).
Hohe Wachstumseinnahmen: DOCUDie Einnahmen des Unternehmens (5.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: DOCUDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (38%)